Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Preferred Stock Liabilities: 2013-2016

Historic Preferred Stock Liabilities for Armata Pharmaceuticals (ARMP) over the last 2 years, with Mar 2016 value amounting to $13.6 million.

  • Armata Pharmaceuticals' Preferred Stock Liabilities rose 484.84% to $13.6 million in Q1 2016 from the same period last year, while for Mar 2016 it was $13.6 million, marking a year-over-year increase of 484.84%. This contributed to the annual value of $11.9 million for FY2015, which is 497.49% up from last year.
  • Armata Pharmaceuticals' Preferred Stock Liabilities amounted to $13.6 million in Q1 2016, which was up 14.51% from $11.9 million recorded in Q4 2015.
  • Armata Pharmaceuticals' 5-year Preferred Stock Liabilities high stood at $46.3 million for Q1 2014, and its period low was $2.0 million during Q4 2014.
  • Over the past 3 years, Armata Pharmaceuticals' median Preferred Stock Liabilities value was $11.9 million (recorded in 2015), while the average stood at $15.4 million.
  • Per our database at Business Quant, Armata Pharmaceuticals' Preferred Stock Liabilities tumbled by 95.12% in 2014 and then soared by 497.49% in 2015.
  • Over the past 4 years, Armata Pharmaceuticals' Preferred Stock Liabilities (Quarterly) stood at $40.8 million in 2013, then plummeted by 95.12% to $2.0 million in 2014, then spiked by 497.49% to $11.9 million in 2015, then surged by 484.84% to $13.6 million in 2016.
  • Its last three reported values are $13.6 million in Q1 2016, $11.9 million for Q4 2015, and $10.9 million during Q3 2015.